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ABSTRACT
Objective To quantify the rate of perinatal mortal-
ity in monochorionic monoamniotic (MCMA) twin
pregnancies, according to gestational age, and to
ascertain the incidence of mortality in pregnancies
managed as inpatients compared with those managed
as outpatients.
Methods MEDLINE, EMBASE and CINAHL databases
were searched for studies on monoamniotic twin preg-
nancy. The primary outcomes explored were the inci-
dence of intrauterine death (IUD), neonatal death (NND)
and perinatal death (PND) in MCMA twins at different
gestational-age windows (24–30, 31–32, 33–34, 35–36
and ≥37 weeks of gestation). The secondary outcomes
were the incidence of IUD, NND and PND in MCMA
twins according to the type of fetal monitoring (inpatient
vs outpatient), and the incidence of delivery ahead of
schedule. Random-effects model meta-analyses were used
to analyze the data.
Results Twenty-five studies (1628 non-anomalous twins
reaching 24weeks of gestation) were included. Single
and double intrauterine deaths occurred in 2.5%
Correspondence to: Dr F. D’Antonio, Department of Obstetrics and Gynecology, University Hospital of Northern Norway, Department of
Clinical Medicine, Faculty of Health Sciences, UiT – The Arctic University of Norway, Hansine Hansens veg 18, 9019 Tromsø, Norway
(e-mail: francesco.dantonio@uit.no)
Accepted: 27 July 2018
(95% CI, 1.8–3.3%) and 3.8% (95% CI, 2.5–5.3%)
of cases, respectively. IUD occurred in 4.3% (95% CI,
2.8–6.2%) of twins at 24–30weeks, in 1.0% (95%
CI, 0.6–1.7%) at 31–32weeks and in 2.2% (95% CI,
0.9–3.9%) at 33–34weeks of gestation, while there
was no case of IUD, either single or double, from
35weeks of gestation. In MCMA twin pregnancies
managed mainly as inpatients, the incidence of IUD was
3.0% (95% CI, 1.4–5.2%), while the corresponding
figure for those managed mainly as outpatients was
7.4% (95% CI, 4.4–11.1%). Finally, 37.8% (95%
CI, 28.0–48.2%) of MCMA pregnancies were delivered
before the scheduled time, due mainly to spontaneous
preterm labor or abnormal cardiotocographic findings.
Conclusions MCMA twins are at high risk of perinatal
loss during the third trimester of pregnancy, with the
large majority of such losses occurring as apparently
unexpected events. Inpatient management seems to be
associated with a lower rate of mortality, although further
studies are needed in order to establish the appropriate
type and timing of prenatal assessment in these
pregnancies. Copyright  2018 ISUOG. Published by
John Wiley & Sons Ltd.
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INTRODUCTION
Chorionicity is the main determinant of perinatal
outcome in twin pregnancy. Monochorionic (MC)
twin pregnancies are at higher risk of perinatal
mortality and morbidity compared with dichorionic (DC)
pregnancies due to the excess risk of preterm birth, growth
discordance and complications unique to MC placentas,
such as twin–twin transfusion syndrome (TTTS), twin
reversed arterial perfusion (TRAP) sequence and selective
intrauterine growth restriction1–7. Prenatal identification
of monochorionic monoamniotic (MCMA) twins is
fundamental because monoamnionicity carries a further
increased risk of adverse pregnancy outcome compared
with MC diamniotic pregnancies, thus ideally requiring a
tailored approach8.
Despite this, the optimal type of management of
MCMA pregnancy has still to be elucidated. There is
no randomized controlled trial addressing the type and
frequency of follow-up in MCMA pregnancy, and no
specific recommendation on how to manage MCMA
twins has been provided by the different national bodies.
MCMA pregnancies are usually delivered between 32 and
34weeks of gestation in view of the reported high risk
of unexpected fetal loss with advancing gestation9. The
antenatal management protocol of monoamniotic twins is
also controversial, with some studies advocating inpatient
follow-up of these pregnancies with serial ultrasound and
cardiotocographic (CTG) assessment, while others report
no difference in the perinatal outcome between cases
managed as inpatients and those managed as outpatients9.
However, published studies are likely to be biased by their
retrospective design, small sample size and inclusion of
cases with fetal anomalies, thus making it difficult to
extrapolate robust evidence of the actual risk of perinatal
mortality in these pregnancies.
The primary aim of this systematic review was to
quantify the incidence of perinatal mortality in MCMA
twin pregnancies, according to gestational age. The
secondary aim was to ascertain the risk of mortality in
pregnancies managed as inpatients compared with those
managed as outpatients.
METHODS
Protocol, eligibility criteria, information sources
and search
This review was performed according to an
a-priori-designed protocol recommended for systematic
reviews and meta-analyses10. MEDLINE, EMBASE and
CINAHL were searched electronically on 17 December
2017 and updated on 17 July 2018, utilizing combina-
tions of the relevant medical subject heading (MeSH)
terms, keywords and word variants for ‘monoamniotic’,
‘twin pregnancies’ and ‘outcome’ (Table S1). The search
and selection criteria were restricted to the English
language. Reference lists of relevant articles and reviews
were hand-searched for additional reports. PRISMA and
MOOSE guidelines were followed11,12. The study was
registered with the PROSPERO database (registration
number: CRD42016043062).
Study selection, data collection and data items
The primary outcome explored in the present systematic
review was the incidence of intrauterine death (IUD),
neonatal death (NND) and perinatal death (PND)
inMCMA twins in the following gestational agewindows:
24–30weeks, 31–32weeks, 33–34weeks, 35–36weeks
and ≥ 37 weeks.
IUD was defined as fetal demise from 24weeks of
gestation and was divided into single (sIUD) and double
(dIUD) according to the death of one or both twins,
respectively. NND was defined as the death of at
least one of the newborns up to 28 days postpartum,
while PND was defined as IUD plus NND. We also
aimed to categorize the cause of IUD into those related
to the presence of TTTS or growth restriction and
those that were sudden or unexpected, defined as IUD
occurring in a MCMA twin without a prior recognizable
chronic condition such as transfusion events or growth
abnormalities.
The secondary outcomes were the incidence of IUD,
NND and PND in twins according to the type of
fetal monitoring. For the purpose of this analysis, twin
pregnancies were divided into those admitted electively to
the hospital for fetal monitoring (inpatients) and those
followed up as outpatients. Finally, we explored the
incidence of delivery ahead of schedule in MCMA twin
pregnancies scheduled for elective delivery at 32weeks
and those scheduled for delivery between 32 and 34weeks
of gestation.
Only studies reporting the number of MCMA twin
pregnancies in each gestational-age window and the
relative number of deaths were considered suitable for
inclusion. Studies including cases with fetal anomaly were
excluded in view of the higher risk of mortality in twins
affected by structural or chromosomal anomaly. Only
full-text articles were considered eligible for inclusion.
Case reports, conference abstracts and case series with
fewer than three cases were excluded to avoid publication
bias. Furthermore, studies published before 2000were not
included, as advances in management of twin pregnancies
make them less relevant.
Two authors (F.D., D.B.) reviewed all abstracts
independently. Agreement regarding potential relevance
was reached by consensus; full-text copies of those papers
were obtained and the same two reviewers independently
extracted relevant data regarding study characteristics and
pregnancy outcome. Inconsistencies were discussed by the
reviewers and consensus was reached between them or by
discussion with a third author. If more than one study was
published on the same cohort with identical endpoints, the
report containing the most comprehensive information
on the population was included to avoid overlapping
populations. For those articles in which information was
not reported but the methodology was such to suggest
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that this information would have been recorded initially,
the authors were contacted.
Quality assessment of the included studies was
performed using the Newcastle–Ottawa Scale (NOS) for
case–control studies. According to NOS, each study is
judged on three broad perspectives: selection of the study
groups, comparability of the groups and ascertainment of
the outcome of interest13. Assessment of the selection of a
study includes the evaluation of the representativeness of
the exposed cohort, selection of the non-exposed cohort,
ascertainment of exposure, and demonstration that the
outcome of interest was not present at the start of study.
Assessment of the comparability of the study includes
evaluation of the comparability of cohorts based on the
design or analysis. Finally, ascertainment of the outcome
of interest includes evaluation of the type of assessment of
the outcome of interest, length and adequacy of follow-up.
According to NOS, a study can be awarded a maximum
of one star for each numbered item within the selection
and outcome categories. A maximum of two stars can be
given for comparability13.
Statistical analysis
The prevalence of each of the explored outcomes
was evaluated in MCMA twins, overall and according
to gestational age; the overall number of fetuses was
used as the denominator for each proportion. Proportion
meta-analysis using a random-effects model to account
for interstudy heterogeneity was used to analyze the data.
Potential publication bias was assessed either graphically,
displaying the odds ratios of individual studies vs the
logarithm of their standard errors (funnel plots), or
formally, using Egger’s regression asymmetry test14. Tests
for publication bias were not performed when the overall
number of included studies was less than 10, in view
of their low power15. All analyses were carried out
using STATA, version 13.1 (Stata Corp., College Station,
TX, USA).
RESULTS
General characteristics
A total of 607 articles were identified and assessed
with respect to their eligibility for inclusion. Of
those, 53 had the full text assessed for eligibility
and 25 were included in the systematic review (Table 1,
Figure 1)16–40. Table S2 lists the excluded studies and
the reason for exclusion. The 25 studies included
1068 MCMA pregnancies (2136 twins); information on
perinatal mortality according to the gestational age at
loss was provided for 814 non-anomalous twin pairs
(1628 twins) reaching 24weeks of gestation, which
represent the population analyzed in this systematic
review.
Table 1 General characteristics of included studies on outcome of monoamniotic twin pregnancy
Study Country
Study
design
Study
period Antenatal management
GA at
delivery
(weeks)
Pregnancies
(n)
Saccone (2019)16 Italy, Spain, UK, USA Retro 2010–2017 Inpatient or outpatient 32–34 185
Glinianaia (2019)17 UK Retro 2000–2013 Inpatient or outpatient 32–35 55
Kristiansen (2015)18 Denmark Retro 2008–2011 Outpatient 34 24
Prefumo (2015)19 Italy Retro 2004–2013 Inpatient 32 20
Anselem (2015)20 France Retro 1993–2014 Outpatient 36 38
Van Mieghem (2014)21 Canada, Belgium, The
Netherlands, Austria,
Switzerland, USA
Retro 2003–2012 Inpatient or outpatient 32–34 193
Aurioles-Garibay (2014)22 USA Retro 2007–2013 Inpatient 32 6
Murata (2013)23 Japan Retro 2001–2011 Inpatient 32–34 38
Suzuki (2013)24 Japan Retro NS NS Up to 39 18
Dias (2011)25 UK Retro 1997–2008 Outpatient 34 30
Quinn (2011)26 USA Retro 2000–2009 Inpatient 34 13
Assuncao (2010)27 Brazil Retro 2003–2006 Inpatient or outpatient 34 38
Baxi (2010)28 USA Retro 2001–2009 Inpatient 34 25
Hack (2009)29 The Netherlands Retro 2000–2007 Inpatient or outpatient 32–34 98
Arabin (2009)30 The Netherlands Retro NS Outpatient NS 17
Heflin (2008)31 USA Retro NS Outpatient 33–34 3
Cordero (2006)32 USA Retro 1990–2005 Inpatient or outpatient 32–34 36
Pasquini (2006)33 UK Retro 1994–2005 Outpatient 32 20
DeFalco (2006)34 USA Retro 1991–2001 Inpatient or outpatient NS 23
Heyborne (2005)35 USA Retro 1993–2003 Inpatient or outpatient 32–34 96
Ezra (2005)36 Israel Retro 1986–2002 Inpatient or outpatient NS 33
Demaria (2004)37 France Retro 1993–2001 Outpatient 36 19
Sau (2003)38 UK Retro 1994–2000 Outpatient 32 7
Allen (2001)39 Canada Retro 1993–2000 Inpatient or outpatient 32–35 25
Sebire (2000)40 UK Retro 1992–1998 Inpatient or outpatient 34 8
Only first author is given for each study. GA, gestational age; NS, not stated; Retro, retrospective.
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Figure 1 Flowchart of inclusion of studies on outcome of
monoamniotic twin pregnancy.
Table 2 Quality assessment according to Newcastle–Ottawa Scale
of included studies on outcome of monoamniotic twin pregnancy
Study Selection Comparability Outcome
Saccone (2019)16 ⋆⋆⋆ ⋆⋆ ⋆⋆
Glinianaia (2019)17 ⋆⋆⋆ ⋆⋆ ⋆⋆
Kristiansen (2015)18 ⋆⋆⋆ ⋆ ⋆⋆
Prefumo (2015)19 ⋆⋆ ⋆ ⋆⋆
Anselem (2015)20 ⋆⋆ ⋆ ⋆⋆
Van Mieghem (2014)21 ⋆⋆⋆ ⋆ ⋆⋆
Aurioles-Garibay (2014)22 ⋆⋆ ⋆ ⋆
Murata (2013)23 ⋆⋆ ⋆ ⋆⋆
Suzuki (2013)24 ⋆⋆ ⋆ ⋆
Dias (2011)25 ⋆⋆ ⋆ ⋆
Quinn (2011)26 ⋆⋆ ⋆⋆ ⋆⋆
Assuncao (2010)27 ⋆⋆ ⋆ ⋆
Baxi (2010)28 ⋆⋆ ⋆ ⋆⋆
Hack (2009)29 ⋆⋆ ⋆ ⋆
Arabin (2009)30 ⋆ ⋆ ⋆
Heflin (2008)31 ⋆⋆ ⋆ ⋆⋆
Cordero (2006)32 ⋆⋆ ⋆ ⋆⋆
Pasquini (2006)33 ⋆⋆⋆ ⋆ ⋆⋆
DeFalco (2006)34 ⋆⋆ ⋆ ⋆⋆
Heyborne (2005)35 ⋆⋆⋆ ⋆ ⋆⋆
Ezra (2005)36 ⋆⋆ ⋆ ⋆
Demaria (2004)37 ⋆⋆ ⋆ ⋆⋆
Sau (2003)38 ⋆⋆ ⋆ ⋆
Allen (2001)39 ⋆⋆ ⋆ ⋆⋆
Sebire (2000)40 ⋆ ⋆ ⋆
Only first author is given for each study. Study can be awarded
maximum of one star for each numbered item within selection and
outcome categories. Maximum of two stars can be given for
comparability.
The results of quality assessment of the included
studies using the NOS are presented in Table 2. Most
of the included studies showed an overall good score
regarding the selection and comparability of the study
groups, as well as for ascertainment of the outcome
of interest. The main weaknesses of these studies were
their retrospective design, small sample size, different
gestational ages at ultrasound examination and lack of
information on prenatal management of twins affected by
weight discordance.
Synthesis of results
Twenty-four studies including 814 non-anomalous
MCMA pregnancies (1628 twins) reaching 24weeks of
gestation explored the incidence of mortality according
to gestational age. Overall IUD, including either sIUD
or dIUD, occurred in 5.8% (95% CI, 4.0–8.1%) of
twins, while the corresponding figures for sIUD and dIUD
were 2.5% (95% CI, 1.8–3.3%) and 3.8% (95% CI,
2.5–5.3%). The incidence of NND was 2.6% (95% CI,
1.9–3.4%) (Table 3, Figure 2).
The incidence of mortality varied according to
gestational-age window. IUD occurred in 4.3% (95%
Table 3 Pooled proportions of overall, single (sIUD) and double
(dIUD) intrauterine death (IUD), and neonatal (NND) and
perinatal (PND) death in monoamniotic twins, overall and
according to gestational age
Outcome
Studies
(n)
Fetuses
(n/N)
Pooled proportions
(95% CI) (%)
I2
(%)
Overall mortality
Overall IUD 24 106/1628 5.84 (4.0–8.1) 59.0
sIUD 24 38/1628 2.53 (1.8–3.3) 0
dIUD* 24 68/1628 3.77 (2.5–5.3) 44.2
NND 24 37/1628 2.56 (1.9–3.4) 0
PND 24 143/1628 7.91 (5.9–10.2) 51.7
24–30weeks
Overall IUD 24 84/1628 4.32 (2.8–6.2) 54.1
sIUD 24 30/1628 1.99 (1.4–2.7) 0
dIUD* 24 54/1628 2.87 (1.8–4.2) 41.8
NND 24 35/1628 2.45 (1.8–3.3) 0
PND 24 119/1628 6.21 (4.4–8.3) 51.1
31–32weeks
Overall IUD 24 11/1266 1.03 (0.6–1.7) 0
sIUD 24 5/1266 0.59 (0.2–1.1) 0
dIUD* 24 6/1266 0.71 (0.3–1.2) 0
NND 24 2/1266 0.59 (0.2–1.1) 0
PND 24 13/1266 1.30 (0.7–2.0) 0
33–34weeks
Overall IUD 18 11/606 2.16 (0.9–3.9) 28.4
sIUD 18 3/606 0.99 (0.4–1.9) 0
dIUD* 18 8/606 1.56 (0.6–3.0) 24.6
NND 18 0/606 0 (0–1.4) 0
PND 18 11/606 2.16 (0.9–3.9) 28.4
35–36weeks
Overall IUD 11 0/150 0 (0–4.0) 0
sIUD 11 0/150 0 (0–4.0) 0
dIUD* 11 0/150 0 (0–4.0) 0
NND 11 0/150 0 (0–4.0) 0
PND 11 0/150 0 (0–4.0) 0
*dIUD counted as double event.
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Dias (2011)25
Quinn (2011)26
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Arabin (2009)30
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Cordero (2006)32
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Heyborne (2005)35
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Allen (2001)39
Sebire (2000)40
Combined
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Proportion (95% CI)
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Figure 2 Pooled proportions (95% CI) of overall intrauterine death in monochorionic monoamniotic twin pregnancy.
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Figure 3 Point estimates (95% CI) of intrauterine death (IUD)
rates in monochorionic monoamniotic twin pregnancy, according
to gestational age.
CI, 2.8–6.2%) of cases at 24–30weeks, 1.0% (95%
CI, 0.6–1.7%) at 31–32weeks and in 2.2% (95% CI,
0.9–3.9%) at 33–34weeks of gestation, while there
was no IUD, either single or double, from 35weeks of
gestation, although the sample size was small (Table 3,
Figure 3).
sIUD and dIUD occurred, respectively, in 2.0% (95%
CI, 1.4–2.7%) and 2.9% (95% CI, 1.8–4.2%) of twins
at 24–30weeks, 0.6% (95% CI, 0.2–1.1%) and 0.7%
(95% CI, 0.3–1.2%) at 31–32weeks, and 1.0% (95%
CI, 0.4–1.9%) and 1.6% (95% CI, 0.6–3.0%) of cases
at 33–34weeks of gestation. Finally, NND occurred in
2.5% (95% CI, 1.8–3.3%) of cases at 24–30weeks and
0.6% (95% CI, 0.2–1.1%) at 31–32weeks, while there
was no death later in gestation (Table 3).
When analyzing those studies reporting the etiology of
IUD, 29.5% (95% CI, 13.5–48.8%; I2= 55.2%) of the
overall losses were due to TTTS or growth restriction,
while 54.0% (95% CI, 37.1–71.3%; I2=42.8%)
were unexpected IUD. Furthermore, from 31weeks of
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Figure 4 Pooled proportions (95% CI) of overall intrauterine death in monochorionic monoamniotic twin pregnancies managed mainly as
inpatients (a) and those managed mainly as outpatients (b).
Table 4 Pooled proportions of overall, single (sIUD) and double
(dIUD) intrauterine death (IUD), and neonatal (NND) and
perinatal (PND) death in monoamniotic twins treated mainly as
inpatients and those treated mainly as outpatients
Outcome
Studies
(n)
Fetuses
(n/N)
Pooled
proportions
(95% CI) (%)
I2
(%)
Inpatient management
Overall IUD 12 19/610 3.02 (1.4–5.2) 40.7
sIUD 12 9/610 1.85 (0.9–3.1) 0
dIUD* 12 10/610 1.61 (0.5–3.3) 39.8
NND 12 8/610 1.52 (0.7–2.6) 0
PND 12 27/610 3.72 (1.5–6.9) 63.5
Outpatient management
Overall IUD 14 67/830 7.40 (4.4–11.1) 63.5
sIUD 14 17/830 2.38 (1.2–4.0) 29.6
dIUD* 14 50/830 5.33 (3.2–8.0) 46.9
NND 14 21/830 2.65 (1.6–3.9) 6.4
PND 14 88/830 9.53 (5.9–13.9) 67.0
*dIUD counted as double event.
gestation, all IUDs included in the present systematic
review were reported to be unexpected and not the
consequence of a chronic condition that can be potentially
identified in utero.
Twenty studies reported the incidence of mortality in
pregnancies managed mainly as inpatients and/or those
followed up as outpatients. In MCMA twin pregnancies
managed mainly as inpatients, the incidence of IUD was
3.0% (95% CI, 1.4–5.2%), while the corresponding
figures for sIUD and dIUD were 1.9% (95% CI,
0.9–3.1%) and 1.6% (95% CI, 0.5–3.3%) (Figure 4,
Table 4). Conversely, in MCMA twin pregnancies
managed mainly as outpatients, IUD occurred in 7.4%
(95% CI, 4.4–11.1%) of twins, while sIUD and dIUD
occurred in 2.4% (95% CI, 1.2–4.0%) and 5.3% (95%
CI, 3.2–8.0%), respectively.
In pregnancies managed mainly as inpatients, 27.9%
(95% CI, 10.4–49.9%; I2= 0%) of the IUDs were due
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Table 5 Pooled proportions of delivery ahead of schedule in monoamniotic twin pregnancy
Outcome
Studies
(n)
Pregnancies
(n/N)
Pooled proportions
(95% CI) (%)
I2
(%)
All
Overall 15 216/606 37.81 (28.0–48.2) 79.7
Delivery due to PTB 13 65/178 35.73 (29.0–51.6) 72.2
Delivery due to CTG anomaly 13 80/178 39.15 (23.6–55.9) 73.6
Delivery due to other reason 13 33/178 23.85 (12.0–38.52) 68.9
Delivery scheduled at 32weeks
Overall 5 6/39 18.46 (6.5–34.8) 24.8
Delivery due to PTB 4 1/6 22.05 (20.1–55.0) 0
Delivery due to CTG anomaly 4 1/6 22.64 (13.4–59.0) 15.8
Delivery due to other reason 4 4/6 64.37 (28.2–93.0) 12.3
Delivery scheduled at 32–34weeks
Overall 7 154/474 34.70 (26.6–43.2) 65.2
Delivery due to PTB 5 52/112 39.96 (21.0–60.6) 75.1
Delivery due to CTG anomaly 5 38/112 35.40 (17.2–56.1) 75.4
Delivery due to other reason 5 22/112 22.90 (7.1–44.2) 79.5
CTG, cardiotocography; PTB, preterm birth.
to TTTS or growth restriction, while 62.8% (95%
CI, 34.0–87.4%; I2= 31.0%) were unexpected. The
corresponding figures for cases managed mainly as
outpatients were 12.0% (95% CI, 4.1–23.2%; I2= 0%)
and 69.3% (95% CI, 46.7–87.9%; I2= 32.8%).
Finally, the rate of delivery ahead of schedule was
explored. Overall, 37.8% (95% CI, 28.0–48.2%) of
MCMA pregnancies were delivered before the scheduled
time, due mainly to spontaneous preterm labor or
abnormal CTG findings. In MCMA twin pregnancies
scheduled for delivery at 32weeks of gestation, the
rate of delivery before this time was 18.5% (95%
CI, 6.5–34.8%), while the corresponding figure for
those scheduled between 32 and 34weeks was 34.7%
(95% CI, 26.6–43.2%) (Table 5). When stratifying the
analysis according to the type of prenatal management
adopted, the risk of unexpected delivery was 44.9% (95%
CI, 28.7–61.6%) and 42.3% (95% CI, 26.4–59.4%)
in pregnancies managed mainly as inpatients and
those managed mainly as outpatients, respectively. In
pregnancies managed mainly as inpatients, 22.7% (95%
CI, 10.3–38.2%) and 44.9% (95% CI, 28.7–61.6%)
of unexpected deliveries were due to preterm birth and
CTG abnormalities, respectively, while the corresponding
figures for pregnancies managed mainly as outpatients
were 16.4% (95% CI, 10.4–23.4%) and 16.7% (95%
CI, 5.9–31.4%).
DISCUSSION
Main findings
The findings of this systematic review show that
the overall incidence of fetal loss in MCMA pregnancies
is approximately 6%. The large majority of fetal losses
occurred before 30weeks of gestation, while the risk
of demise at 31–32 and 33–34weeks of gestation was
1% and 2%, respectively. Most IUDs were unexpected,
thus questioning the optimal type of assessment in these
pregnancies. Finally, the incidence of fetal loss in twins
of pregnancies managed mainly as inpatients was 3%
as compared with 7% in those followed up as outpatients.
Despite this, the heterogeneity in the type of prenatal
assessment among the included studies highlights the need
for developing an adequate protocol for prenatal
management of MCMA twin pregnancies, focusing on the
type and frequency of follow-up rather than admission
to the hospital.
Strengths and limitations
The small number of cases in some of the included studies,
their retrospective non-randomized design, dissimilarity
of the populations (due to varied inclusion criteria)
and lack of standardized criteria for the antenatal
management of MCMA twin pregnancies represent
themajor limitations of this systematic review. Assessment
of potential publication bias was also problematic because
of the nature of the outcome evaluated (outcome rates,
with the left-side limited to a value of zero), which
limits the reliability of funnel plots, and because of the
scarce number of individual studies, which strongly limits
the reliability of formal tests. Another major limitation
of this systematic review is represented by differences
in the antenatal management of MCMA pregnancies
in terms of type and frequency of assessment. Despite
these limitations, the present review represents the most
comprehensive published estimate of the investigated
outcomes in MCMA twin pregnancies.
Implications for clinical practice
Management of MCMA twin pregnancy is challenging.
As there are no randomized trials assessing the optimal
prenatal management of MCMA pregnancies in terms
of type and frequency of follow-up and gestational
age at delivery, it is not possible to provide specific
recommendations on how to manage these pregnancies.
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It is true that MCMA twins are rare; however, prenatal
identification of those pregnancies is fundamental in their
risk stratification and tailoring their antenatal care4.
In the present systematic review, only 30% of IUDs
were due to recognizable conditions such as TTTS or
growth abnormalities, while the large majority of them
occurred unexpectedly. However, prenatal diagnosis of
TTTS in MCMA twin pregnancy is challenging and not
based upon classical ultrasound features observed in these
pregnancies. Polyhydramnios and non-visualization of the
bladder in one of the twins are usually the first signs of
TTTS in MCMA twin pregnancy. In this scenario, it may
be entirely possible that some of the fetal losses labeled
as unexpected were the result of undiagnosed TTTS. This
highlights the need for thorough regular examination of
MCMA twins in order to look for signs of TTTS, such
as amniotic fluid volume, visualization of the bladder and
fetal Doppler.
Timing of delivery of apparently uncomplicated
MCMA twins is still debated. It is common practice
to deliver MCMA twins between 32 and 34weeks of
gestation, in view of the reported high risk of IUD
in the third trimester of pregnancy. However, most of
the previously published studies included fetuses with
anomalies, which are at higher risk of fetal loss, and come
from an era in which the natural history of TTTS had
not been systematically elucidated, thus explaining the
high rate of deaths labeled as unexpected in otherwise
apparently uncomplicated MCMA twins.
The findings of this review showed that fetal loss
occurs in 1% of MCMA twins at 31–32weeks and
2% at 33–34weeks of gestation; furthermore, double
fetal demises affected about 2% of twins at 33–34weeks
of gestation, thus highlighting the need for a thorough
follow-up if the pregnancy is continued beyond 32weeks.
A policy of elective delivery at 32weeks of gestation may
look appropriate in view of the apparently higher risk of
fetal demise occurring later on in gestation, but should be
balanced against the potentially higher risk of neonatal
morbidity. However, a large proportion of MCMA twins
will be delivered before the scheduled time, especially as
a consequence of spontaneous preterm labor.
The type of prenatal follow-up of MCMA twin
pregnancy is also controversial. Some studies claim that
elective admission to the hospital in the third trimester
may improve the outcome of MCMA pregnancy, while
others have shown no difference. Furthermore, there is
as yet no consensus on when to start intensive follow-up
and monitoring.
In the present systematic review, the incidence of fetal
loss was 3% in twins of pregnancies managed mainly as
inpatients compared with 7% in those of pregnancies fol-
lowed up as outpatients. However, there was significant
heterogeneity in the management protocols among the
included studies, which might have biased the results. Fur-
thermore, comparison between inpatient and outpatient
monitoring was affected by the largest study included
in the analysis16. In that study, outpatient surveillance
was started at 30weeks for the majority of included
centers, whereas inpatient surveillance was started at
24weeks. Deaths in the outpatient group occurred before
30weeks (i.e. before initiation of surveillance), while
after 30weeks, the number of deaths in the inpatient and
outpatient cohorts was very similar (1.4 vs 2.4%).
The perinatal outcome of MC pregnancies is dependent
not only on the degree of placental sharing between the
twins but also on the direction and the magnitude of blood
flow through the intertwin anastomoses. MCMA twins
have a lower risk of developing TTTS compared with
MCDApregnancies due to their peculiar vascular arrange-
ment with nearby placental insertions of the umbilical
cords and the large arterioarterial anastomoses. However,
acute unpredictable transfusion events can still occur3.
An adequate prenatal management of monoamniotic
twins should include serial assessment of the amniotic
fluid, fetal urinary bladders and Doppler studies to rule
out signs of TTTS. It is unclear whether systematic
evaluation of umbilical cords to diagnose entanglement
may reduce the risk of fetal loss, as many of them are acute
events that may not be easily predicted. Regarding the
frequency of fetal monitoring, a twice-weekly scan starting
from 24–26weeks of gestation has been proposed in view
of the high rate of perinatal loss occurring at 24–30weeks
of gestation. Despite this, parental counseling should
stress the fact that a normal scan cannot completely
rule out adverse events, as they may occur acutely.
Further large studies are needed in order to develop
objective protocols for antenatal surveillance of MCMA
twins, aiming at reducing the risk of perinatal mortality
and morbidity in these pregnancies. Considering the
occurrence of IUD in the subgroups of MCMA
pregnancies managed as inpatients and those managed as
outpatients (3.02% and 7.40%, respectively), a minimum
of 806 (403 per group) pregnancies would be needed
to find a difference in mortality according to the two
management options, with a power of 80% and an alpha
error of 0.05.
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Mortal idad perinatal , momento del parto y tratamiento prenatal del embarazo gemelar
monoamnio´t ico: revis i o´n sistema´t ica y metaana´ l is is
RESUMEN
Objetivo Cuantificar la tasa de mortalidad perinatal en los embarazos gemelares monocorio´nicos monoamnio´ticos
(MCMA), en funcio´n de la edad gestacional, y determinar la incidencia de la mortalidad en los embarazos atendidos en
pacientes hospitalizadas en comparacio´n con los atendidos en pacientes ambulatorias.
Me´todos Se realizaron bu´squedas en las bases de datos de MEDLINE, EMBASE y CINAHL dirigidas a estudios sobre
embarazo gemelar monoamnio´tico. Las medidas de resultados primarios examinadas fueron (todas las siglas del ingle´s)
la incidencia de muerte intrauterina (IUD), la muerte neonatal (NND) y la muerte perinatal (PND) en gemelosMCMA en
diferentes edades gestacionales (24–30, 31–32, 33–34, 35–36 y ≥ 37 semanas de gestacio´n). Las medidas de resultados
secundarios fueron la incidencia de IUD, NND y PND en los gemelos MCMA segu´n el tipo de monitorizacio´n fetal
(paciente hospitalizada frente a paciente ambulatoria) y la incidencia de parto prete´rmino. Para analizar los datos se
utilizaron metaana´lisis de modelo de efectos aleatorios.
Resultados Se incluyeron 25 estudios (1628 gemelos no ano´malos que alcanzaron las 24 semanas de gestacio´n). Las
muertes intrauterinas simples (sIUD) y dobles (dIUD) ocurrieron en el 2,5% (IC 95%: 1,8–3,3%) y el 3,8% (IC
95%: 2,5–5,3%) de los casos, respectivamente. La IUD ocurrio´ en el 4,3% (IC 95%: 2,8–6,2%) de los gemelos
a las 24–30 semanas de gestacio´n, en el 1,0% (IC 95%: 0,6–1,7%) a las 31–32 semanas y en el 2,2% (IC 95%:
0,9–3,9%) a las 33–34 semanas, mientras que no hubo ningu´n caso de IUD, ya fuera simple o doble, a partir de las 35
semanas de gestacio´n. En los embarazos gemelares MCMA tratados principalmente como pacientes hospitalizadas, la
incidencia de la IUD fue del 3,0% (IC 95%: 1,4–5,2%), mientras que la cifra correspondiente para las que se trataron
principalmente como pacientes ambulatorias fue del 7,4% (IC 95%: 4,4–11,1%). Finalmente, el parto del 37,8% (IC
95%, 28,0–48,2%) de los embarazos MCMA fue antes del momento programado, debido principalmente a parto
prete´rmino esponta´neo o a hallazgos ano´malos en la CTG.
Conclusiones Los gemelos MCMA tienen un alto riesgo de pe´rdida perinatal durante el tercer trimestre del embarazo, y
la gran mayorı´a de estas pe´rdidas ocurren como eventos aparentemente inesperados. El tratamiento hospitalario parece
estar asociado con una menor tasa de mortalidad, aunque se necesitan estudios adicionales para establecer el tipo y el
momento adecuado de la evaluacio´n prenatal en estos embarazos.
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